Genpact vs Science Applications International
Science Applications International is the larger business, with $7.26bn of revenue in fiscal 2026 against $5.08bn for Genpact (1.4 times as much). Genpact grew faster (6.6% against -2.9%). Genpact kept more of each dollar of sales as profit: a net margin of 10.9% against 4.9%.
| Latest fiscal year | GenpactG, 2025 | Science Applications InternationalSAIC, 2026 |
|---|---|---|
| Revenue | $5.08bn | $7.26bn |
| Revenue growth | 6.6% | -2.9% |
| Net income | $552m | $358m |
| Operating margin | 14.8% | — |
| Net margin | 10.9% | 4.9% |
| Return on equity | 22.4% | 23.3% |
| Free cash flow | $735m | $577m |
| Cash | $854m | $182m |
| Total debt | $1.54bn | $2.49bn |
| Debt to equity | 60.5% | — |
| Dividend per share | $0.68 | — |
| Dividend yield | 1.8% | 1.0% |
| Share buybacks | — | $445m |
| Employees | 146,500 | 23,000 |
| Market value | $6.80bn | $6.40bn |
| Price vs our value range | Below our value range | Within our value range |
| Moat score | 59 (Moderate) | 49 (Moderate) |
| Insider trades, 12 months | 0 buys, 16 sales | 7 buys, 0 sales |